Monday 28 May 2018

EU crisis spells more pain for drugmakers

Drugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France, said experts. Growing alarm at multiple government-imposed cut


Drugmakers chase new markets as US, Europe flop

As sales of big-brand medicines in the United States and Europe falter, Western drug companies have new targets in their sights - the emerging wealthy middle classes of China, India and Russia. And such a drive into new areas of double-dig

 1 2 3 4 5 >  Last ›

calendarCalendar of Events